A New 3D Virtual Reality-based Upper Limb Training to Improve Dexterity in Parkinson's Disease
1 other identifier
interventional
20
1 country
1
Brief Summary
We investigate the impact of a 4-week virtual reality-based upper limb training in Parkinson's disease. The benefits on dexterity of this training program will be evaluated. For these purposes, a randomised, two arm, single assessor blind, parallel design with a monocentric, study setup will be performed.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable parkinson-disease
Started Jul 2023
Typical duration for not_applicable parkinson-disease
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 13, 2023
CompletedStudy Start
First participant enrolled
July 19, 2023
CompletedFirst Posted
Study publicly available on registry
July 28, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedJuly 28, 2023
July 1, 2023
2.5 years
July 13, 2023
July 20, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
fine finger movements
Coin rotation task (CRT): The CRT measures fine coordinated finger movements and is a suitable and valid dexterity test in patients with PD. The seconds for 20 halfturns will be measured.
4 weeks
Secondary Outcomes (5)
hand dexterity
4 weeks
grip strenght
4 weeks
motor function
4 weeks
self-reported dexterity related problems in daily living
4 weeks
self-reported problems in quality of life
4 weeks
Study Arms (2)
Virtual reality upper limb hand training
OTHERThe PD patients randomized in the experimental group will receive virtual reality upper limb hand training.
Virtual reality control training
OTHERThe PD patients randomized in the control group will receive virtual reality control training.
Interventions
The PD patients randomized in the experimental group will receive virtual reality upper limb hand training.
The PD patients randomized in the control group will receive virtual reality control training.
Eligibility Criteria
You may qualify if:
- Patients with confirmed PD, according to UK Brain bank Criteria
- Hoehn \& Yahr Stadium I to IV
- Age 40 to 99 years
- written and signed informed consent
- self-reported dexterous difficulties
You may not qualify if:
- MoCA \<21/30
- psychiatric disease
- participation on other interventional trials
- Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc.
- severe visual impairment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Luzerner Kantonsspital
Lucerne, 6000, Switzerland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Tim Vanbellingen, Prof
Luzerner Kantonsspital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- VR upper limb hand training or VR control training
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 13, 2023
First Posted
July 28, 2023
Study Start
July 19, 2023
Primary Completion
December 31, 2025
Study Completion
December 31, 2025
Last Updated
July 28, 2023
Record last verified: 2023-07
Data Sharing
- IPD Sharing
- Will not share